EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond Wall Thickness: Clinical Predictors of Genotype Positivity in Hypertrophic Cardiomyopathy

Filippo Angelini, Veronica Dusi, Amedeo Maria Feneziani, Rossella Manai, Matteo Bianco, Enrica Lonni, Giulia Margherita Brach Del Prever, Pier Paolo Bocchino, Giuseppe Giannino, Daniele Melis, Giulia Gobello, Francesco Ravera und 12 weitere

Cardiogenetics · 11.05.2026 · 16 (2) · 10

DOI: 10.3390/cardiogenetics16020010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiogenetics, online erschienen am 11.05.2026. Verfasst von Filippo Angelini und 23 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Genetic testing in hypertrophic cardiomyopathy (HCM) yields variable positivity rates. Identifying clinical predictors of positive genetic tests could improve pre-test counseling and refine expectations about diagnostic yield.

Methods

We analyzed consecutive genotyped HCM probands from a contemporary multicenter cohort across four Italian tertiary centers. Genotype positivity was defined as the presence of ≥1 pathogenic or likely pathogenic variant (ACMG classes 4–5). Multivariable logistic regression identified predictors of genotype positivity. Sensitivity analyses assessed the incremental value of left atrial volume index (LAVI) ≥ 34 mL/m2 and the mode of first clinical presentation.

Results

Among 274 genotyped probands (median age at diagnosis 54 years; 62% male), 86 (31%) were genotype-positive (38% MYBPC3, 29% MYH7). Age at diagnosis 20 mm and gender were not predictive of genotype positivity. Inclusion of LAVI modestly improved the model performance (AUC 0.769, p = 0.016, ΔAUC +0.024; DeLong p = 0.016) but without leading to meaningful patient reclassification.

Conclusions

Genotype positivity in HCM links to earlier onset and family history; traditional severity markers and initial presentation may not independently suggest genetic causality. These findings may help shape a personalized approach to genetic counseling in HCM.

Zitieren

APA

Angelini, F., Dusi, V., Feneziani, A. M., Manai, R., Bianco, M., Lonni, E., Prever, G. M. B. D., Bocchino, P. P., Giannino, G., Melis, D., Gobello, G., Ravera, F., Laiso, L. E., Juvenal, F., Gallone, G., Pidello, S., Mabritto, B., Giachino, D., Musumeci, G., …, & Raineri, C. (2026). Beyond Wall Thickness: Clinical Predictors of Genotype Positivity in Hypertrophic Cardiomyopathy. Cardiogenetics, 16(2), 10. https://doi.org/10.3390/cardiogenetics16020010

Vancouver

Angelini F, Dusi V, Feneziani AM, Manai R, Bianco M, Lonni E, et al. Beyond Wall Thickness: Clinical Predictors of Genotype Positivity in Hypertrophic Cardiomyopathy. Cardiogenetics. 2026;16(2):10. doi:10.3390/cardiogenetics16020010

BibTeX
@article{Angelini2026,
  author = {Angelini, Filippo and Dusi, Veronica and Feneziani, Amedeo Maria and Manai, Rossella and Bianco, Matteo and Lonni, Enrica and Prever, Giulia Margherita Brach Del and Bocchino, Pier Paolo and Giannino, Giuseppe and Melis, Daniele and Gobello, Giulia and Ravera, Francesco and Laiso, Lucia Elena and Juvenal, Federico and Gallone, Guglielmo and Pidello, Stefano and Mabritto, Barbara and Giachino, Daniela and Musumeci, Giuseppe and Chinaglia, Alessandra and Marra, Walter Grosso and Deaglio, Silvia and Ferrari, Gaetano Maria De and Raineri, Claudia},
  title = {Beyond Wall Thickness: Clinical Predictors of Genotype Positivity in Hypertrophic Cardiomyopathy},
  journal = {Cardiogenetics},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {10},
  doi = {10.3390/cardiogenetics16020010}
}
Kostenlos starten →